BioStem Technologies (BSEM) to Release Quarterly Earnings on Monday

BioStem Technologies (OTCMKTS:BSEM) is anticipated to announce its earnings results after the market closes on Monday, April 7th. Analysts expect the company to announce earnings of $0.37 per share and revenue of $86.69 million for the quarter.

BioStem Technologies Stock Performance

Shares of BSEM stock opened at $8.29 on Friday. The stock has a market capitalization of $138.48 million, a price-to-earnings ratio of 12.19 and a beta of -0.39. BioStem Technologies has a one year low of $6.77 and a one year high of $28.26. The company’s 50-day simple moving average is $12.76 and its 200-day simple moving average is $13.76.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.